|
Here's the only info I have about it so far. This is just the conclusion of the presentation for your info. The presentation discussed over-expression of HER2 in relation to invasive as well as noninvasive bc.
The clinical relevance of over-expression in ADH and DCIS remains to be clarified.
Paper presented at the International Symposium on Predictive Oncology and Intervention Strategies; Nice, France; February 7 - 10, 2004; in plenary session 801 (Predictive markers & validation).
|